<--- Back to Details
First PageDocument Content
HIV/AIDS in South Africa / Civil disobedience / Treatment Action Campaign / Zackie Achmat / HIV/AIDS denialism / Pre-exposure prophylaxis / Thabo Mbeki / HIV/AIDS / TAC / State of Denial / Manto Tshabalala-Msimang
Date: 2015-06-18 18:16:36
HIV/AIDS in South Africa
Civil disobedience
Treatment Action Campaign
Zackie Achmat
HIV/AIDS denialism
Pre-exposure prophylaxis
Thabo Mbeki
HIV/AIDS
TAC
State of Denial
Manto Tshabalala-Msimang

Study No. 7, AugustIn the Face of Crisis: The Treatment Action Campaign Fights Government Inertia with Budget Advocacy and Litigation Neil Overy1 At the turn of the millennium the South African government allocate

Add to Reading List

Source URL: www.internationalbudget.org

Download Document from Source Website

File Size: 342,15 KB

Share Document on Facebook

Similar Documents

An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis

An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis

DocID: 1ut18 - View Document

Pragmatic Open-Label Randomised Trial of Pre-Exposure Prophylaxis: the PROUD study http://www.proud.mrc.ac.uk/

Pragmatic Open-Label Randomised Trial of Pre-Exposure Prophylaxis: the PROUD study http://www.proud.mrc.ac.uk/

DocID: 1uc90 - View Document

A publication for men and transgender women who have sex with men Pre-exposure Prophylaxis  Is taking PrEP the

A publication for men and transgender women who have sex with men Pre-exposure Prophylaxis Is taking PrEP the

DocID: 1u249 - View Document

Final Draft – 11 MayGuidelines for Expanding Combination Prevention and Treatment Options for Sex Workers: Oral Pre-Exposure Prophylaxis (PrEP) and Test and Treat (T&T)

Final Draft – 11 MayGuidelines for Expanding Combination Prevention and Treatment Options for Sex Workers: Oral Pre-Exposure Prophylaxis (PrEP) and Test and Treat (T&T)

DocID: 1t04u - View Document

Pre-Exposure Prophylaxis (PrEP): A primer for primary care providers Daily emtricitabine/tenofovir (Truvada®) is safe and effective for reducing the risk of HIV acquisition in sexually active men and women and injection

Pre-Exposure Prophylaxis (PrEP): A primer for primary care providers Daily emtricitabine/tenofovir (Truvada®) is safe and effective for reducing the risk of HIV acquisition in sexually active men and women and injection

DocID: 1rPaA - View Document